skip-to-content-text

UPMC Hillman Cancer Center San Pietro FBF


Oncology radiotherapy center that integrates technological innovation, international protocols, and specialized clinical expertise, UPMC Hillman Cancer Center San Pietro FBF was established in 2013 through a collaboration between UPMC (University of Pittsburgh Medical Center) and Ospedale San Pietro Fatebenefratelli.

The Center has been characterized from the outset by a strong drive for innovation: in 2013 it introduced stereotactic radiosurgery (SRS) in the Lazio region; in 2026 it implemented the first Unity system by Elekta in Italy, an advanced linear accelerator for adaptive radiotherapy.

UPMC Hillman Cancer Center San Pietro FBF is part of the international oncology network UPMC Hillman Cancer Center, which includes 80 cancer centers in the United States and Europe and treats more than 185,000 patients each year. All specialists at the Center have completed a training period at UPMC facilities in Pittsburgh, where they acquired the clinical protocols, therapeutic techniques, and quality standards that define the network. This global connection ensures patients access to the latest developments in oncology research and to international best clinical practices.

Accredited by the Joint Commission International (JCI) since 2017, UPMC Hillman Cancer Center San Pietro FBF is affiliated with the Italian National Health Service (SSN) and has agreements with major insurance companies.

Personalized Therapeutic Approach for Each Tumor Site

UPMC Hillman Cancer Center San Pietro FBF treats primary tumors, metastases, and recurrences across all body sites through an integrated multidisciplinary approach. Each patient is supported throughout the entire care pathway by a dedicated team of radiation oncologists, medical physicists, technicians, nurses, and administrative staff working according to protocols shared with the international UPMC Hillman Cancer Center network.

Treatments are personalized based on lesion location, tumor morphology, and the patient’s individual clinical condition. This multidisciplinary integration — supported by continuous consultation with specialists in neurosurgery, medical and surgical oncology, pathology, diagnostic imaging, nursing care, nutrition, and psychology —ensures excellence in treatment quality and comprehensive patient care.

Radiotherapy Techniques

UPMC Hillman Cancer Center San Pietro FBF offers radiotherapy techniques that ensure maximum precision in targeting tumor tissue while preserving surrounding healthy organs. All procedures are performed on an outpatient basis, are non-invasive, painless, and do not require special dressing.

Adaptive Radiotherapy with Unity: Real-Time Monitoring

Unity by Elekta integrates a high-field MRI system (1.5 Tesla) with artificial intelligence for real-time monitoring of patient movement and tumor changes during treatment sessions.

Unlike traditional radiotherapy, treatment parameters are adjusted at the beginning of each session based on real-time imaging, eliminating the need to interrupt treatment for re-planning. The result is reduced treatment times, better protection of healthy organs, and fewer side effects.

Complementary Precision Technologies

UPMC Hillman Cancer Center San Pietro FBF is also equipped with a TrueBeam™ STx, one of the most advanced linear accelerators available, delivering high radiation doses with millimeter precision, reducing treatment times and minimizing exposure to healthy tissue.

The Center uses the Brainlab ExacTrac Dynamic system, which monitors patient micromovements during radiotherapy and automatically compensates for them, ensuring millimeter-level treatment accuracy.

UPMC Hillman Cancer Center San Pietro FBF

Book an appointment now. Phone: 06 88846800.

Find a UPMC Specialist

Search our online directory to a find UPMC specialist. Book an appointment today.

Insurance and Conventions

We offer medical services and services on a private basis or in agreement with the main insurance companies. Some of our services are also affiliated with the National Health System.

For more information on active agreements, visit: